SCHEMBL30798134

SCHEMBL30798134

CC(C)(C)OC(=O)N1Cc2cn(-c3cccc(OCc4ccc(Cl)cn4)n3)nc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 2/20 0.40
GLP1R P43220 1/20 0.39
MAPT P10636 2/20 0.34
PDK2 Q15119 1/20 0.34
GABRA5 P31644 1/20 0.33
GPR119 Q8TDV5 1/20 0.33
ESR2 Q92731 1/20 0.33
C5AR1 P21730 1/20 0.33
DDB1 Q16531 1/20 0.33
CRBN Q96SW2 1/20 0.33
SLC6A9 P48067 2/20 0.32
KCNH2 Q12809 1/20 0.32
CKS1B P61024 1/20 0.32
SKP1 P63208 1/20 0.32
SKP2 Q13309 1/20 0.32
POLB P06746 1/20 0.32
FNTA P49354 1/20 0.32
FNTB P49356 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30798204 0.88 SLC34A1 (0.41) SLC34A1GPR119SLC6A9KCNH2
SCHEMBL30798207 0.80 SLC34A1 (0.41) SLC34A1MAPTPDK2GPR119ESR2
SCHEMBL30798079 0.76 SLC34A1 (0.43) SLC34A1GLP1RGPR119SLC6A9KCNH2
Trifluoroacetic Acid SCHEMBL30797976 0.76 GLP1R (0.38) GLP1R
SCHEMBL30798076 0.75 SLC34A1 (0.42) SLC34A1MAPTPDK2GPR119ESR2
SCHEMBL25248223 0.74 MEN1 (0.45) GLP1RMAPTGPR119POLBLMNA
SCHEMBL20075219 0.72 SLC34A1 (0.50) SLC34A1MAPTPDK2GPR119ESR2
SCHEMBL23361963 0.72 CCNT1 (0.49) MAPTGPR119FNTAFNTB
SCHEMBL25292398 0.72 GRM1 (0.47) GPR119
SCHEMBL29393087 0.72 GRM1 (0.47) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024028795-A1 HETEROBICYCLIC COMPOUNDS AS ORAL GLP1R AGONISTS ZYDUS LIFESCIENCES LIMITED (IN) 2024-02-08 WO disclosed